$DRIO .127 HEADING TO 50 CENTS. I alerted it at 5 cents, it ran over 18 cents in 2 weeks, it's ready again.
"I stole this but its good stuff....
Built my position to 250k shares so far....
DRIO increased the O/S to 72m because they needed to raise money for Dario.
The company is in their soft launch phase, and have 23 employees working for them.
The dilution is Over per Friday's 8-K and the company confirmed
On Dec. 31st, 2013, the market cap at $1.70 and 20M sh. was $34M.
On June 30th, 2014, the market cap at $1.00 and 23M sh. was $23M.
Current market cap with 75M o/s at .07 is $5.25M.
A $20M market cap with the current 75M o/s would be approx. .266.
Keep in mind DRIO held a $34M market cap before the soft launch, and a $23M marketcap after the (very successful) soft launch had been effective for almost 6 months.
During that period, clearly it was the dilution that kept skewing the market cap.
With dilution now complete, along with cash proceeds available from this dilution, recovery of the pps to at least a $20M market cap would not be unrealistic at all.
Now the chart has bottomed out and should start an uptrend as it gets back to a proper market cap.
DARIO IS NOW ENTERING THEIR HARD LINE LAUNCH NEXT WEEK
WHAT THE COMPANY DOES:
Plugs into smart mobile device without the need for additional cords or cables
Fast – entire blood glucose metering process takes only 6 seconds Accurate – highly accurate results with tiny blood sample
Pocket-sized meter – forget about those bulky pouches and fanny packs
No battery – never run out of power and environmentally-friendly
ADDITIONALLY:
Dario is a state-of-the-art diabetes management platform that connects the user, caregiver and healthcare professional anywhere in the world. Dario‘s cloud-based software provides you with an easy seamless way to record, save, track, analyze, manage & share all your diabetes related information in one lifestyle management platform. Through the Dario web portal you can access all your activity and medication data and track your progress. Your data is always in sync and always accessible on-line in a user-friendly interface via a secure Web session. The Dario Web Portal is an easy way to share your profile with caregivers and family members at your discretion.
NEAR TERM CATALYSTS:
•Commenced first shipments of the Dario™ Diabetes Management Solution to distributors in Italy, New Zealand, the United Kingdom and the Netherlands, collecting initial positive feedback from the market of people with diabetes.
•Received reimbursement status in England, Wales, Scotland and Northern Ireland for strips and lancets to be utilized together with the Dario™ smart meter (effective September 1, 2014).
•Working with FDA towards potential clearance of the Dario™ smart meter in the U.S. following a 510K filing made in late December 2013.
•Partnered with FatSecret, a leading global nutrition data source, to integrate such data into the Dario™ Diabetes Management Solution.
•Raised $3.8 million in net proceeds from private placement which had its closing on February 2014.
•LabStyle's business strategy and goals assuming adequate funding for the remainder of 2014 and into 2015 include: Expedite production of Dario™ personalized smart meters for both Android and IOS smartphone operating systems, in selected jurisdictions with maximum optimization and efficiency.
•Obtain 510K FDA clearance for the Dario™ personalized smart meter by early 2015.
CASH IN THE BANK:
LabStyle used approximately $4,418,000 in cash to fund operating activities during the first half of 2014. As of June 30, 2014, LabStyle had cash, cash equivalents, restricted cash and short-term bank deposits of approximately $1,985,000.
KEY POINTS:
The Dario device will be compatible with the Android and IOS Smartphone devices beginning the first week of September.
The company raised this money to,"RAMP UP," their sales and production capabilities which are anticipated to soar GLOBALLY, starting in September.
DRIO is growing itself organically, making the right on the go products, compatible with all cell phone devices and have reoccurring revenue streams being developed by selling the disposable strips. It is highly likely that DRIO will either be acquired, (possibly TRIB), or reach multiple dollars within the next year. Either way, we see DRIO has having tremendous short, intermediate and long term benefits and you can buy this company with confidence as it has a long way to go up to its minimum price range of .30+.
MORE DD
•Received a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims covering the Dario™ personalized smart meter, which works in tandem with the novel and powerful Dario™ software application to form the overall Dario™ Diabetes Management Solution.
•Working with FDA towards potential clearance of the Dario™ smart meter in the U.S. following a 510K filing made in late December 2013.
•Number of Dario™ smart meter users has passed 2,000 and is growing.
THIS IS WHAT HAPPENED:
DRIO increased the O/S to 72m because they needed to raise money for Dario.
The company is in their soft launch phase, and have 23 employees working for them.
The dilution is ever per Friday's 8-K and the company confirmed the key here is this:
The market cap on December 31st was over $30m , June 31st was $23m today the market cap is $5.2m. The PPS for the company to get the market cap of $20m is .266 . safe to say this has huge upside and the company will get the market cap back to proper valuation.
Now the chart has bottomed out and should start an uptrend as it gets back to a proper market cap.
lowman Member Level Tuesday, 08/26/14 12:29:45 PM
Re: TheWizardOfPot post# 772
Post # of 781
To help calibrate the new value of DRIO post-dilution:
Issued and Outstanding: 23,013,889 (unaudited) and 20,071,816 shares at June 30, 2014 and December 31, 2013, respectively.
On Dec. 31st, 2013, the marketcap at $1.70 and 20M sh. was $34M.
On June 30th, 2014, the marketcap at $1.00 and 23M sh. was $23M.
Current marketcap with 75M o/s at .07 is $5.25M.
A $20M marketcap with the current 75M o/s would be approx. .266.
Keep in mind DRIO held a $34M marketcap before the soft launch, and a $23M marketcap after the (very successful) soft launch had been effective for almost 6 months.
During that period, clearly it was the dilution that kept skewing the marketcap.
With dilution now complete, along with cash proceeds available from this dilution, recovery of the pps to at least a $20M marketcap would not be unrealistic at all.
EMAIL FROM DRIO
JJL Member Level Sunday, 08/24/14 10:14:25 AM
Re: None
Post # of 262
Jason,
We understand the frustration of investors given the current share price.
The board and management are diligently pursuing the steps detailed in our August 14th press release, which you can read in the link below:
mydario.investorroom.com/2014-08-15-LabStyle-Innovations-Reports-2014-Second-Quarter-Results-and-Anticipated-Milestones-for-the-Remainder-of-the-Year
Also, I can confirm that as per our 8k we filed on Friday, we have completed issuing all the shares in respect of our February financing.
From: JASON [mailto: ]
Sent: Sunday, August 24, 2014 3:59 PM
To: Info
Subject: DRIO stock
To whom it may concern:
I recently purchased some of your stock at .067 per share. I think I got a good price. However, the stock fell more. Is it possible to have a press release saying if the company is thru selling the extra shares or how the company is doing. If you can just respond to this email that would be nice.
Thanks,
Jason
Confirmation DD
Dated 28th of July 2014
(Reuters) - LabStyle Innovations Corp said on Monday it has received approval from Israel's Ministry of Health to sell its Dario smart meter for diabetes in Israel.
The market launch of Dario began in late March in the United Kingdom, Italy, and New Zealand. In early 2014 LabStyle said it filed an application with the U.S. Food and Drug Administration to market the Dario system.
LabStyle said it plans to market Dario in six additional territories by the end of 2014.
Dario is a cloud-based, diabetes management solution that allows diabetics to monitor their blood sugars and gain insights into managing their disease using their mobile devices.
According to the International Diabetes Federation, diabetes affects more than 8 percent of adults in Israel from the age of 20-79 and its prevalence is growing. (Reporting by Tova Cohen)
They have 4,370,485 left on reserve for potential future issuance which means a MUCH HIGHER PPS The rebound my friends is in session!!!
"
http://www.thelifesciencesreport.com/pub/na/no-title-16146
"I stole this but its good stuff....
Built my position to 250k shares so far....
DRIO increased the O/S to 72m because they needed to raise money for Dario.
The company is in their soft launch phase, and have 23 employees working for them.
The dilution is Over per Friday's 8-K and the company confirmed
On Dec. 31st, 2013, the market cap at $1.70 and 20M sh. was $34M.
On June 30th, 2014, the market cap at $1.00 and 23M sh. was $23M.
Current market cap with 75M o/s at .07 is $5.25M.
A $20M market cap with the current 75M o/s would be approx. .266.
Keep in mind DRIO held a $34M market cap before the soft launch, and a $23M marketcap after the (very successful) soft launch had been effective for almost 6 months.
During that period, clearly it was the dilution that kept skewing the market cap.
With dilution now complete, along with cash proceeds available from this dilution, recovery of the pps to at least a $20M market cap would not be unrealistic at all.
Now the chart has bottomed out and should start an uptrend as it gets back to a proper market cap.
DARIO IS NOW ENTERING THEIR HARD LINE LAUNCH NEXT WEEK
WHAT THE COMPANY DOES:
Plugs into smart mobile device without the need for additional cords or cables
Fast – entire blood glucose metering process takes only 6 seconds Accurate – highly accurate results with tiny blood sample
Pocket-sized meter – forget about those bulky pouches and fanny packs
No battery – never run out of power and environmentally-friendly
ADDITIONALLY:
Dario is a state-of-the-art diabetes management platform that connects the user, caregiver and healthcare professional anywhere in the world. Dario‘s cloud-based software provides you with an easy seamless way to record, save, track, analyze, manage & share all your diabetes related information in one lifestyle management platform. Through the Dario web portal you can access all your activity and medication data and track your progress. Your data is always in sync and always accessible on-line in a user-friendly interface via a secure Web session. The Dario Web Portal is an easy way to share your profile with caregivers and family members at your discretion.
NEAR TERM CATALYSTS:
•Commenced first shipments of the Dario™ Diabetes Management Solution to distributors in Italy, New Zealand, the United Kingdom and the Netherlands, collecting initial positive feedback from the market of people with diabetes.
•Received reimbursement status in England, Wales, Scotland and Northern Ireland for strips and lancets to be utilized together with the Dario™ smart meter (effective September 1, 2014).
•Working with FDA towards potential clearance of the Dario™ smart meter in the U.S. following a 510K filing made in late December 2013.
•Partnered with FatSecret, a leading global nutrition data source, to integrate such data into the Dario™ Diabetes Management Solution.
•Raised $3.8 million in net proceeds from private placement which had its closing on February 2014.
•LabStyle's business strategy and goals assuming adequate funding for the remainder of 2014 and into 2015 include: Expedite production of Dario™ personalized smart meters for both Android and IOS smartphone operating systems, in selected jurisdictions with maximum optimization and efficiency.
•Obtain 510K FDA clearance for the Dario™ personalized smart meter by early 2015.
CASH IN THE BANK:
LabStyle used approximately $4,418,000 in cash to fund operating activities during the first half of 2014. As of June 30, 2014, LabStyle had cash, cash equivalents, restricted cash and short-term bank deposits of approximately $1,985,000.
KEY POINTS:
The Dario device will be compatible with the Android and IOS Smartphone devices beginning the first week of September.
The company raised this money to,"RAMP UP," their sales and production capabilities which are anticipated to soar GLOBALLY, starting in September.
DRIO is growing itself organically, making the right on the go products, compatible with all cell phone devices and have reoccurring revenue streams being developed by selling the disposable strips. It is highly likely that DRIO will either be acquired, (possibly TRIB), or reach multiple dollars within the next year. Either way, we see DRIO has having tremendous short, intermediate and long term benefits and you can buy this company with confidence as it has a long way to go up to its minimum price range of .30+.
MORE DD
•Received a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims covering the Dario™ personalized smart meter, which works in tandem with the novel and powerful Dario™ software application to form the overall Dario™ Diabetes Management Solution.
•Working with FDA towards potential clearance of the Dario™ smart meter in the U.S. following a 510K filing made in late December 2013.
•Number of Dario™ smart meter users has passed 2,000 and is growing.
THIS IS WHAT HAPPENED:
DRIO increased the O/S to 72m because they needed to raise money for Dario.
The company is in their soft launch phase, and have 23 employees working for them.
The dilution is ever per Friday's 8-K and the company confirmed the key here is this:
The market cap on December 31st was over $30m , June 31st was $23m today the market cap is $5.2m. The PPS for the company to get the market cap of $20m is .266 . safe to say this has huge upside and the company will get the market cap back to proper valuation.
Now the chart has bottomed out and should start an uptrend as it gets back to a proper market cap.
lowman Member Level Tuesday, 08/26/14 12:29:45 PM
Re: TheWizardOfPot post# 772
Post # of 781
To help calibrate the new value of DRIO post-dilution:
Issued and Outstanding: 23,013,889 (unaudited) and 20,071,816 shares at June 30, 2014 and December 31, 2013, respectively.
On Dec. 31st, 2013, the marketcap at $1.70 and 20M sh. was $34M.
On June 30th, 2014, the marketcap at $1.00 and 23M sh. was $23M.
Current marketcap with 75M o/s at .07 is $5.25M.
A $20M marketcap with the current 75M o/s would be approx. .266.
Keep in mind DRIO held a $34M marketcap before the soft launch, and a $23M marketcap after the (very successful) soft launch had been effective for almost 6 months.
During that period, clearly it was the dilution that kept skewing the marketcap.
With dilution now complete, along with cash proceeds available from this dilution, recovery of the pps to at least a $20M marketcap would not be unrealistic at all.
EMAIL FROM DRIO
JJL Member Level Sunday, 08/24/14 10:14:25 AM
Re: None
Post # of 262
Jason,
We understand the frustration of investors given the current share price.
The board and management are diligently pursuing the steps detailed in our August 14th press release, which you can read in the link below:
mydario.investorroom.com/2014-08-15-LabStyle-Innovations-Reports-2014-Second-Quarter-Results-and-Anticipated-Milestones-for-the-Remainder-of-the-Year
Also, I can confirm that as per our 8k we filed on Friday, we have completed issuing all the shares in respect of our February financing.
From: JASON [mailto: ]
Sent: Sunday, August 24, 2014 3:59 PM
To: Info
Subject: DRIO stock
To whom it may concern:
I recently purchased some of your stock at .067 per share. I think I got a good price. However, the stock fell more. Is it possible to have a press release saying if the company is thru selling the extra shares or how the company is doing. If you can just respond to this email that would be nice.
Thanks,
Jason
Confirmation DD
Dated 28th of July 2014
(Reuters) - LabStyle Innovations Corp said on Monday it has received approval from Israel's Ministry of Health to sell its Dario smart meter for diabetes in Israel.
The market launch of Dario began in late March in the United Kingdom, Italy, and New Zealand. In early 2014 LabStyle said it filed an application with the U.S. Food and Drug Administration to market the Dario system.
LabStyle said it plans to market Dario in six additional territories by the end of 2014.
Dario is a cloud-based, diabetes management solution that allows diabetics to monitor their blood sugars and gain insights into managing their disease using their mobile devices.
According to the International Diabetes Federation, diabetes affects more than 8 percent of adults in Israel from the age of 20-79 and its prevalence is growing. (Reporting by Tova Cohen)
They have 4,370,485 left on reserve for potential future issuance which means a MUCH HIGHER PPS The rebound my friends is in session!!!
"
http://www.thelifesciencesreport.com/pub/na/no-title-16146
